Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs

被引:41
作者
Su, JL
Simmons, CJ
Wisely, B
Ellis, B
Winegar, DA
机构
[1] Glaxo Wellcome Inc, Res & Dev, Dept Mol Sci, Res Triangle Pk, NC 27709 USA
[2] Glaxo Wellcome Inc, Res & Dev, Dept Funct Genet, Res Triangle Pk, NC 27709 USA
[3] Glaxo Wellcome Inc, Res & Dev, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
[4] Glaxo Wellcome Inc, Res & Dev, Dept Metab Dis, Res Triangle Pk, NC 27709 USA
来源
HYBRIDOMA | 1998年 / 17卷 / 01期
关键词
D O I
10.1089/hyb.1998.17.47
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report the production and characterization of two PPAR alpha subtype-specific monoclonal antibodies raised against the N-terminal domain of PPAR alpha. P alpha b11.80A is a Western-reactive antibody, whereas P alpha b32.51 is useful for immunohistochemistry. Both antibodies exhibited high affinity against the immunogen based on BIAcore analysis, recognized full-length PPAR alpha protein in PPAR alpha-transfected CV-1 cells, and displayed no cross-reactivity against the N-terminal domains of PPAR gamma or PPAR delta proteins as demonstrated by various immunoassays, The application of these antibodies to a panel of normal human tissues revealed that PPAR alpha protein expression is highest in skeletal muscle, liver, and kidney, consistent with previously reported mRNA expression data, These antibodies provide us with valuable tools to further explore the function of PPAR alpha.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 25 条
  • [1] AUBOEUF D, 1997, TISSUE DISTRIBUTION, V46, P1319
  • [2] BATTIFORA H, 1986, LAB INVEST, V55, P244
  • [3] CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA
    BOURGUET, W
    RUFF, M
    CHAMBON, P
    GRONEMEYER, H
    MORAS, D
    [J]. NATURE, 1995, 375 (6530) : 377 - 382
  • [4] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
    Braissant, O
    Foufelle, F
    Scotto, C
    Dauca, M
    Wahli, W
    [J]. ENDOCRINOLOGY, 1996, 137 (01) : 354 - 366
  • [5] Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle
    Cresci, S
    Wright, LD
    Spratt, JA
    Briggs, FN
    Kelly, DP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (05): : C1413 - C1420
  • [6] DESVERGNE B, 1995, INDUCIBLE GENE EXPRE, V1, P142
  • [7] CONTROL OF THE PEROXISOMAL BETA-OXIDATION PATHWAY BY A NOVEL FAMILY OF NUCLEAR HORMONE RECEPTORS
    DREYER, C
    KREY, G
    KELLER, H
    GIVEL, F
    HELFTENBEIN, G
    WAHLI, W
    [J]. CELL, 1992, 68 (05) : 879 - 887
  • [8] Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2
    Elbrecht, A
    Chen, YL
    Cullinan, CA
    Hayes, N
    Leibowitz, MD
    Moller, DE
    Berger, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) : 431 - 437
  • [9] BIOSPECIFIC INTERACTION ANALYSIS USING SURFACE-PLASMON RESONANCE DETECTION APPLIED TO KINETIC, BINDING-SITE AND CONCENTRATION ANALYSIS
    FAGERSTAM, LG
    FROSTELLKARLSSON, A
    KARLSSON, R
    PERSSON, B
    RONNBERG, I
    [J]. JOURNAL OF CHROMATOGRAPHY, 1992, 597 (1-2): : 397 - 410
  • [10] Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
    Forman, BM
    Chen, J
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4312 - 4317